Home › NDC Lookup › RxCUI directory › RxCUI 1726319

2 ML irinotecan hydrochloride 20 MG/ML Injection — RxCUI 1726319

RxNorm drug concept · Semantic clinical drug
RxCUI 1726319 Semantic clinical drug · SCD ● Current RxNorm concept 26 FDA products 34 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1726319
Official name2 ML irinotecan hydrochloride 20 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asirinotecan HCl 40 MG per 2 ML Injection; irinotecan HCl 40 MG in 2 ML Injection
FDA products mapped26
Package NDCs mapped34
Reported Medicaid activity (SDUD)23,820 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Irinotecan Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Irinotecan is a chemotherapy drug used for colorectal cancer — specifically cancer of the colon or rectum that has spread to other parts of the body. It can be used as part of your...
  • What exactly is irinotecan being used to treat?
  • Irinotecan is given through an IV drip — it's not a pill. Each infusion typically takes about 90 minutes and is done in a clinic or infusion center. How often you go in depends on...
  • How will I receive this medication, and how often will I need to go in?
📖 Read our full Irinotecan Injection guide →

🕸️ Concept Web — How 2 ML irinotecan hydrochloride 20 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML irinotecan hydrochloride 20 MG/ML Injection RxCUI 1726319

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Irinotecan 51499
    • Irinotecan hydrochloride 153329
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Camptosar 203652
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Irinotecan Injection 1726318
    • Irinotecan hydrochloride Injection 2647503
    • Irinotecan Injectable Product 1161334
    • Irinotecan hydrochloride Injectable Product 2660189
    • Irinotecan Injection [Camptosar] 1726320
    • Irinotecan hydrochloride Injection [Camptosar] 2656798
    • Camptosar Injectable Product 1172305
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Irinotecan hydrochloride 20 MG/ML SCDC · 904159
  • Irinotecan Injection SCDF · 1726318
  • Irinotecan hydrochloride Injection SCDFP · 2647503
  • Irinotecan Injectable Product SCDG · 1161334
  • Irinotecan hydrochloride Injectable Product SCDGP · 2660189

Brand-Name Concepts

  • 2 ML irinotecan hydrochloride 20 MG/ML Injection [Camptosar] SBD · 1726321
  • Irinotecan hydrochloride 20 MG/ML [Camptosar] SBDC · 904161
  • Irinotecan Injection [Camptosar] SBDF · 1726320
  • Irinotecan hydrochloride Injection [Camptosar] SBDFP · 2656798
  • Camptosar Injectable Product SBDG · 1172305
  • Camptosar BN · 203652

📦 FDA Products & Package NDCs

26 products · 34 package NDCs
34 package NDCs map to RxCUI 1726319 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-0082-02 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-0082-02) / 15 mL in 1... Camptosar Pharmacia & Upjohn Company LLC 2024-06-24
00009-0112-05 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-0112-05) / 5 mL in 1... Camptosar Pharmacia & Upjohn Company LLC 2024-12-30
00009-7529-05 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-05) / 15 mL in 1... Camptosar Pharmacia & Upjohn Company LLC 1996-06-14
00009-7529-10 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-10) / 2 mL in 1... Camptosar Pharmacia & Upjohn Company LLC 2024-12-30
00143-9701-01 5 mL in 1 VIAL, GLASS (0143-9701-01) Irinotecan Hydrochloride Hikma Pharmaceuticals USA Inc. 2010-12-20
00143-9702-01 2 mL in 1 VIAL, GLASS (0143-9702-01) Irinotecan Hydrochloride Hikma Pharmaceuticals USA Inc. 2010-12-20
16714-0027-01 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-027-01) / 2 mL in 1... Irinotecan hydrochloride Northstar Rx LLC 2020-11-15
16714-0131-01 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-131-01) / 5 mL in 1... Irinotecan hydrochloride Northstar Rx LLC 2020-11-15
25021-0230-02 1 VIAL in 1 CARTON (25021-230-02) / 2 mL in 1 VIAL Irinotecan Hydrochloride Sagent Pharmaceuticals 2014-08-15
25021-0230-05 1 VIAL in 1 CARTON (25021-230-05) / 5 mL in 1 VIAL Irinotecan Hydrochloride Sagent Pharmaceuticals 2014-08-15
45963-0614-51 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-51) / 2 mL in 1... Irinotecan hydrochloride Actavis Pharma, Inc. 2015-03-12
45963-0614-55 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-55) / 5 mL in 1... Irinotecan hydrochloride Actavis Pharma, Inc. 2015-03-12
50742-0401-02 1 VIAL, GLASS in 1 CARTON (50742-401-02) / 2 mL in 1 VIAL,... Irinotecan Hydrochloride Ingenus Pharmaceuticals, LLC 2017-06-05
50742-0402-05 1 VIAL, GLASS in 1 CARTON (50742-402-05) / 5 mL in 1 VIAL,... Irinotecan Hydrochloride Ingenus Pharmaceuticals, LLC 2017-06-05
55150-0352-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-352-01) / 2 mL in 1... IRINOTECAN HYDROCHLORIDE Eugia US LLC 2020-02-11
55150-0353-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-353-01) / 5 mL in 1... IRINOTECAN HYDROCHLORIDE Eugia US LLC 2020-02-11
55150-0354-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-354-01) / 15 mL in 1... IRINOTECAN HYDROCHLORIDE Eugia US LLC 2020-02-11
55150-0355-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-355-01) / 25 mL in 1... IRINOTECAN HYDROCHLORIDE Eugia US LLC 2022-04-11
60505-6128-00 1 VIAL, SINGLE-USE in 1 CARTON (60505-6128-0) / 2 mL in 1 V... Irinotecan Hydrochloride Apotex Corp. 2017-11-30
60505-6128-01 1 VIAL, SINGLE-USE in 1 CARTON (60505-6128-1) / 5 mL in 1 V... Irinotecan Hydrochloride Apotex Corp. 2017-11-30
61703-0349-09 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-09) / 5 mL in 1... Irinotecan Hydrochloride Hospira, Inc. 2008-02-27
61703-0349-16 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-16) / 2 mL in 1... Irinotecan Hydrochloride Hospira, Inc. 2008-02-27
61703-0349-36 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-36) / 25 mL in 1... Irinotecan Hydrochloride Hospira, Inc. 2008-02-27
63323-0193-52 1 VIAL in 1 BOX (63323-193-52) / 2 mL in 1 VIAL Irinotecan Hydrochloride Fresenius Kabi USA, LLC 2009-04-01
63323-0193-55 1 VIAL in 1 BOX (63323-193-55) / 5 mL in 1 VIAL Irinotecan Hydrochloride Fresenius Kabi USA, LLC 2009-04-01
67184-0511-01 1 VIAL, SINGLE-USE in 1 CARTON (67184-0511-1) / 2 mL in 1 V... Irinotecan Hydrochloride Qilu Pharmaceutical Co., Ltd. 2016-05-03
67184-0512-01 1 VIAL, SINGLE-USE in 1 CARTON (67184-0512-1) / 5 mL in 1 V... Irinotecan Hydrochloride Qilu Pharmaceutical Co., Ltd. 2016-05-03
67184-0513-01 1 VIAL, SINGLE-USE in 1 CARTON (67184-0513-1) / 15 mL in 1... Irinotecan Hydrochloride Qilu Pharmaceutical Co., Ltd. 2016-05-03
68001-0480-22 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-480-22) / 5 mL in 1... Irinotecan hydrochloide BluePoint Laboratories 2020-12-14
68001-0480-35 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-480-35) / 2 mL in 1... Irinotecan hydrochloide BluePoint Laboratories 2020-12-14
68083-0381-01 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-381-01) / 2 mL in 1... Irinotecan hydrochloide Gland Pharma Limited 2019-11-18
68083-0382-01 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-382-01) / 5 mL in 1... Irinotecan hydrochloride Gland Pharma Limited 2019-11-18
70700-0169-22 1 VIAL, SINGLE-DOSE in 1 CARTON (70700-169-22) / 2 mL in 1... Irinotecan hydrochloide Xiromed LLC 2019-11-18
70700-0170-22 1 VIAL, SINGLE-DOSE in 1 CARTON (70700-170-22) / 5 mL in 1... Irinotecan hydrochloride Xiromed LLC 2019-11-18
Observed labelers: Eugia US LLC (4) · Pharmacia & Upjohn Company LLC (4) · Hospira, Inc. (3) · Qilu Pharmaceutical Co., Ltd. (3) · Actavis Pharma, Inc. (2) · Apotex Corp. (2) · +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9206 Irinotecan injection 28 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.